<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04171167</url>
  </required_header>
  <id_info>
    <org_study_id>R17011</org_study_id>
    <nct_id>NCT04171167</nct_id>
  </id_info>
  <brief_title>The Causal Relation of Nasal Nitric Oxide Levels to the Severity of Chronic Rhinosinusitis and Its Inflammatory Phenotype</brief_title>
  <official_title>The Causal Relation of Nasal Nitric Oxide Levels to the Severity of Chronic Rhinosinusitis and Its Inflammatory Phenotype</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nitric oxide (NO) reflects changes in inflammatory state of the airways. In pulmonology
      fractional exhaled nitric oxide concentration (FeNO) has been linked to eosinophilic asthma
      and is used to guide overall disease control. The measurement of nasal nitric oxide (nNO) may
      reflect the disease burden and inflammatory phenotype of the paranasal sinuses.

      The aim of our study is to evaluate the relation of chronic rhino sinusitis (CRS) severity
      and inflammatory status to nNO, maxillary sinus NO, nitrite, nitrate and cone beam computed
      tomography (CBCT).

      Three groups (22 patients in each) of referred patients and and 22 healthy volunteers are
      recruited. Patients are grouped according to the CBCT score and viewed three times in 4-6
      weeks intervals.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 4, 2017</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nasal nitric oxide levels</measure>
    <time_frame>Change between visit: 0, +5 weeks, +10weeks</time_frame>
    <description>Gaseous nitric oxide is measured nasal cavity and maxillary sinuses using EcoMedics CLD 88p analyser (ppb). Procedure according to ERS protocol.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Nitric oxide metabolite (nitrate, nitrite) levels</measure>
    <time_frame>Change between visit: 0, +5 weeks, +10weeks</time_frame>
    <description>NO production is determined from saline lavage of nasal cavity and maxillary sinus by measuring the accumulation of nitrite, a stable metabolite of NO in aqueous milieu, by the Griess reaction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CBCT (Zinreich modified Lund-Mackay) scoring</measure>
    <time_frame>Change between visit: 0, +5 weeks, +10weeks</time_frame>
    <description>A routine high resolution cone beam computed tomography (CBCT) is done to evaluate the initial status of the patients nose and repeated (with ultra-low-dose protocol) at every visit to demonstrate the the current state.
Opasification score scale 0-5, max. 50 and obstruction score 0-1 (0,5 steps), max. 8.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Chronic Rhinosinusitis (Diagnosis)</condition>
  <arm_group>
    <arm_group_label>Frequently treated acute rhino sinusitis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Does not meet the European position paper criteria of CRS: asymptomatic periods in between and no objective findings when entering the study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CRSsNP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Meets the European position paper criteria of CRS. Zinreich modification of Lund-Mackey scoringing: Opacification score &lt; 21 and obstruction score 0-8. No visible nasal polyps in endoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Severe CRSsNP and CRSwNP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Meets the European position paper criteria of CRS and not included in the first two groups.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No nasal symptoms or complaints. No interventions done.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluticasone Propionate</intervention_name>
    <description>three visits: 0, after washout, after FP usage</description>
    <arm_group_label>CRSsNP</arm_group_label>
    <arm_group_label>Frequently treated acute rhino sinusitis</arm_group_label>
    <arm_group_label>Severe CRSsNP and CRSwNP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients willing to participate in the study

          -  Patients who are referred to ENT clinic due to chronic rhinosinusitis (EPOS criteria)
             or repeatedly diagnosed and treated acute rhinosinusitis

        Exclusion Criteria:

          -  Endoscopic sinus surgery operation previously

          -  Septal deviation that would need an operation to correct the air flow

          -  Other severe disease that could pose a risk for the patient during the measurements
             based on the judgement of the treating physician

          -  Pregnancy or breastfeeding

          -  Allergy to used medications

          -  Inability to co-operate or to tolerate manipulation of the nose
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tamminen</last_name>
    <phone>+358 03 311611</phone>
    <email>studyregp@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamminen</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>October 23, 2018</study_first_submitted>
  <study_first_submitted_qc>November 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2019</study_first_posted>
  <last_update_submitted>May 13, 2020</last_update_submitted>
  <last_update_submitted_qc>May 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nasal nitric oxide</keyword>
  <keyword>Nitric oxide metabolites</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluticasone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

